{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:29:48Z","timestamp":1789806588557,"version":"4.0.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123221","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:29:04Z","timestamp":1731029344000},"page":"123221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Polycystic ovary syndrome: Recent research and therapeutic advancements"],"prefix":"10.1016","volume":"359","author":[{"given":"Shanmugapriya","family":"Dilliyappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanthika Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Venkatesalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirunavukkarasu","family":"Palaniyandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomathy","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Sivaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Shivaranjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123221_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3329\/dmcj.v7i2.45567","article-title":"Polycystic ovary syndrome: a brief review with recent updates","volume":"7","author":"Shermin","year":"2019","journal-title":"Delta Med. Coll. J."},{"key":"10.1016\/j.lfs.2024.123221_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0025","first-page":"533","article-title":"The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis","volume":"17","author":"Naz","year":"2019","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.lfs.2024.123221_bb0030","first-page":"57","article-title":"Herbal plants used in the treatment of PCOS-A comprehensive review","volume":"15","author":"Kumari","year":"2024","journal-title":"Int. J. Pharma Prof. Res. (IJPPR)."},{"key":"10.1016\/j.lfs.2024.123221_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2024.100159","article-title":"When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments","author":"Unfer","year":"2024","journal-title":"Endocr. Metab. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2024.123221_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/RD9.0000000000000088","article-title":"An overview of the physiopathology and various treatment strategies for polycystic ovary syndrome","volume":"80","author":"Rajabi","year":"2024","journal-title":"Reprod. Dev. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"T.R ESHRE","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.lfs.2024.123221_bb0060","unstructured":"E.A. Kandaraki, O. Papalou, Polycystic Ovary Syndrome and Environmental Toxins."},{"key":"10.1016\/j.lfs.2024.123221_bb0065","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7570\/jomes21043","article-title":"Unravelling polycystic ovary syndrome and its comorbidities","volume":"30","author":"Kim","year":"2021","journal-title":"J. Obes. Metab. Syndr."},{"key":"10.1016\/j.lfs.2024.123221_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.coemr.2020.02.014","article-title":"Medical treatment and comorbidity in polycystic ovary syndrome: an updated review","volume":"12","author":"Glintborg","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000101538","article-title":"Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth","volume":"68","author":"Harwood","year":"2007","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.lfs.2024.123221_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-12-800094-6.00002-9","article-title":"Free testosterone: clinical utility and important analytical aspects of measurement","volume":"63","author":"Shea","year":"2014","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.lfs.2024.123221_bb0090","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17446651.2021.1865152","article-title":"Tailoring treatment for PCOS phenotypes","volume":"16","author":"Papadakis","year":"2021","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0120","unstructured":"https:\/\/www.researchgate.net\/publication\/374544086_WHAT_IS_PCOD_AND_PCOS_A_COMPREHENSIVE_AYURVEDIC_PERSPECTIVES (Lovekush Singh) (October, 2023)."},{"key":"10.1016\/j.lfs.2024.123221_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1573404818666220208110240","article-title":"Polycystic ovarian syndrome: current situation of female hormonal disorder","volume":"19","author":"Chaturvedi","year":"2023","journal-title":"Curr. Women's Health Rev."},{"key":"10.1016\/j.lfs.2024.123221_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","article-title":"Racial and ethnic disparities in polycystic ovary syndrome","volume":"119","author":"VanHise","year":"2023","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.lfs.2024.123221_bb0145","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/diagnostics12081922","article-title":"Hirsutism, normal androgens and diagnosis of PCOS","volume":"12","author":"Spritzer","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.lfs.2024.123221_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clindermatol.2017.09.009","article-title":"Alopecia and the metabolic syndrome","volume":"36","author":"Lie","year":"2018","journal-title":"Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123221_bb0155","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/jc.2018-02548","article-title":"Female pattern hair loss and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee","volume":"104","author":"Carmina","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.lfs.2024.123221_bb0165","series-title":"A Guide to Hormonal Dermatology","first-page":"123","article-title":"PCOS-management of androgenetic Alopecia","author":"Savitha","year":"2024"},{"key":"10.1016\/j.lfs.2024.123221_bb0175","series-title":"Human Reproductive and Prenatal Genetics","first-page":"531","article-title":"Genetic basis of metabolism and inflammation in PCOS","author":"Pang","year":"2023"},{"key":"10.1016\/j.lfs.2024.123221_bb0185","first-page":"10436","article-title":"Fetal metabolic programming in the etiology of polycystic ovarian syndrome","volume":"3","author":"da Silva","year":"2023","journal-title":"RevistaContempor\u00e2nea"},{"issue":"9","key":"10.1016\/j.lfs.2024.123221_bb0190","first-page":"54","article-title":"Contemporary knowledge on the genetic basis of polycystic ovarian syndrome","volume":"121","author":"Bhattacharyya","year":"2023","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.lfs.2024.123221_bb0195","article-title":"Exploring hormone regulation-associated genes as novel targets for gene therapy in polycystic ovary syndrome (PCOS)","volume":"7","author":"Zaveri","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2024.123221_bb0200","article-title":"Role of genetic, environmental, and hormonal factors in the progression of PCOS: a review","volume":"3","author":"Kumar","year":"2022","journal-title":"J. Reprod. Healthc. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0205","first-page":"533","article-title":"Etiological role of environmental toxicants in polycystic ovarian syndrome","volume":"6","author":"Rozati","year":"2019","journal-title":"Hormones"},{"key":"10.1016\/j.lfs.2024.123221_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2024.123221_bb0220","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/life13041056","article-title":"Pathophysiological effects of contemporary lifestyle on evolutionary-conserved survival mechanisms in polycystic ovary syndrome","volume":"13","author":"Parker","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.lfs.2024.123221_bb0225","article-title":"Effect of dietary regimen on the development of polycystic ovary syndrome: a narrative review","volume":"15","author":"Alomran","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2024.123221_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1358755","article-title":"PCOS stratification for precision diagnostics and treatment","volume":"12","author":"Joshi","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2024.123221_bb0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/microorganisms10030578","article-title":"Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options","volume":"10","author":"Hrncir","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2024.123221_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.747888","article-title":"Effects of sleeve gastrectomy on fecal gut microbiota and short-chain fatty acid content in a rat model of polycystic ovary syndrome","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/clinem\/dgab028","article-title":"Changes in ghrelin and glucagon following a low glycemic load diet in women with PCOS","volume":"106","author":"Hoover","year":"2021","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0250","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2024.123221_bb0255","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0260","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.123221_bb0265","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.lfs.2024.123221_bb0270","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms23084334","article-title":"The role of glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome","volume":"23","author":"Bednarz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13224-016-0851-9","article-title":"Polycystic ovarian syndrome: is it time to rename pcos to ha-pods?","volume":"66","author":"Khadilkar","year":"2016","journal-title":"J. Obstet. Gynecol. India"},{"key":"10.1016\/j.lfs.2024.123221_bb0280","first-page":"1099","article-title":"Practical approach to hyperandrogenism in women","volume":"105","author":"Sharma","year":"2021","journal-title":"Med. Clin."},{"key":"10.1016\/j.lfs.2024.123221_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/andro.2021.0020","article-title":"Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies","volume":"3","author":"Kanbour","year":"2022","journal-title":"Androgens Clin. Res. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.123221_bb0290","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e32832afd4d","article-title":"Androgens and polycystic ovary syndrome","volume":"16","author":"Nisenblat","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.lfs.2024.123221_bb0295","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2024.123221_bb0305","article-title":"Basics of androgen synthesis and action","volume":"36","author":"Elzenaty","year":"2022","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0310","first-page":"66","article-title":"The synthesis and metabolism of steroid hormones, Yen & Jaffe\u2019s reproductive","author":"Strauss","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2024.123221_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2478\/abmj-2023-0002","article-title":"Hormone imbalance in polycystic ovarian syndrome","volume":"6","author":"J\u00ceTC\u0102","year":"2023","journal-title":"Acta Biol. Marisiensis"},{"key":"10.1016\/j.lfs.2024.123221_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-019-0505-5","article-title":"Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice","volume":"12","author":"Fujibe","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212507","article-title":"Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0330","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3390\/life13112124","article-title":"Prolactin in polycystic ovary syndrome: metabolic effects and therapeutic prospects","volume":"13","author":"Mastnak","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.lfs.2024.123221_bb0335","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.lfs.2024.123221_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100085","article-title":"A review: brief insight into polycystic ovarian syndrome","volume":"3","author":"Bulsara","year":"2021","journal-title":"Endocr. Metab. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0345","first-page":"1","article-title":"The complementary and alternative medicine for polycystic ovary syndrome: a review of clinical application and mechanism","author":"Jia","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in polycystic ovary syndrome women: an update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.lfs.2024.123221_bb0360","first-page":"14","article-title":"Insulin resistance in polycystic ovarian syndrome","volume":"14","author":"Purwar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2024.123221_bb0365","article-title":"Implications and progression of peroxiredoxin 2 (PRDX2) in various human diseases","volume":"155080","author":"Balasubramanian","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2024.123221_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117841","article-title":"Microfluidics as diagnostic tools","author":"Kumar","year":"2024","journal-title":"ClinicaChimica Acta"},{"key":"10.1016\/j.lfs.2024.123221_bb0375","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/ejendo\/lvad067","article-title":"Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States","volume":"188","author":"Dwivedi","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697137.2023.2282689","article-title":"Polycystic ovary syndrome: associations with cardiovascular disease","volume":"27","author":"Benham","year":"2024","journal-title":"Climacteric"},{"key":"10.1016\/j.lfs.2024.123221_bb0390","doi-asserted-by":"crossref","DOI":"10.5604\/12321966.1226842","article-title":"Cardiovascular system diseases in patients with polycystic ovary syndrome-the role of inflammation process in this pathology and possibility of early diagnosis and prevention","volume":"23","author":"Marciniak","year":"2016","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0395","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2024.123221_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101378","article-title":"Impact of thyroid disease on fertility and assisted conception","volume":"34","author":"Unuane","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0405","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2230-8210.146860","article-title":"Thyroid disorders and polycystic ovary syndrome: an emerging relationship","volume":"19","author":"Singla","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0415","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics"},{"key":"10.1016\/j.lfs.2024.123221_bb0420","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2024.123221_bb0430","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/biomedicines11061567","article-title":"Immunological and metabolic causes of infertility in polycystic ovary syndrome","volume":"11","author":"Kici\u0144ska","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.123221_bb0435","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/humrep\/deu076","article-title":"The role of AMH in anovulation associated with PCOS: a hypothesis","volume":"29","author":"Homburg","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2024.123221_bb0440","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2024.123221_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2022.151895","article-title":"Development of patient derived organoids for cancer drug screening applications","volume":"124","author":"Baskar","year":"2022","journal-title":"Acta Histochem."},{"key":"10.1016\/j.lfs.2024.123221_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154643","article-title":"Role of homeobox d10 gene targeted signaling pathways in cancers","author":"Surendran","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2024.123221_bb0455","article-title":"Biomarker-specific biosensors revolutionise breast cancer diagnosis","volume":"555","author":"Wahab","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2024.123221_bb0460","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09513590.2020.1730794","article-title":"The polycystic ovary syndrome and gynecological cancer risk","volume":"36","author":"Meczekalski","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0465","series-title":"Polycystic Ovary Syndrome and Risk of Breast Cancer in Premenopausal and Postmenopausal Women: A Nationwide Population-based Cohort Study","author":"Frandsen","year":"2024"},{"key":"10.1016\/j.lfs.2024.123221_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: a metaanalysis","volume":"25","author":"Johnson","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.123221_bb0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2019.10.011","article-title":"Controversial association between polycystic ovary syndrome and breast cancer","volume":"243","author":"Carvalho","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.lfs.2024.123221_bb0485","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dei420","article-title":"The association between polycystic ovaries and endometrial cancer","volume":"21","author":"Pillay","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2024.123221_bb0490","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.AOG.0000269047.46078.28","article-title":"Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium","volume":"110","author":"MacLaughlan","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.lfs.2024.123221_bb0495","series-title":"Seminars in reproductive medicine, \u00a9 Thieme Medical Publishers","first-page":"062","article-title":"Polycystic ovary syndrome and endometrial cancer","author":"Navaratnarajah","year":"2008"},{"key":"10.1016\/j.lfs.2024.123221_bb0500","article-title":"Risk of gynecological cancers in women with polycystic ovary syndrome and the pathophysiology of association","volume":"15","author":"Shetty","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2024.123221_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-015-0139-1","article-title":"The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome","volume":"8","author":"Chen","year":"2015","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0510","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.30441","article-title":"Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study","volume":"140","author":"Harris","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2024.123221_bb0515","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/0366-6999.198931","article-title":"Ovarian fibrosis: a phenomenon of concern","volume":"130","author":"Zhou","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.lfs.2024.123221_bb0520","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2024.123221_bb0525","first-page":"235","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center, Archives of","volume":"64","author":"Taranto","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0530","article-title":"Characteristics of polycystic ovary syndrome throughout life","volume":"14","author":"Louwers","year":"2020","journal-title":"Ther. Adv. Reprod. Health."},{"key":"10.1016\/j.lfs.2024.123221_bb0535","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/beem.2002.0203","article-title":"Adult polycystic ovary syndrome begins in childhood","volume":"16","author":"Franks","year":"2002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0545","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","article-title":"Placental steroidogenesis in pregnant women with polycystic ovary syndrome","volume":"166","author":"Maliqueo","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.lfs.2024.123221_bb0550","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0555","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2024.123221_bb0560","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/REP-10-0074","article-title":"Focus on obesity","volume":"140","author":"Denison","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.lfs.2024.123221_bb0565","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","article-title":"Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype","volume":"108","author":"de Wilde","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0570","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fertnstert.2013.05.023","article-title":"Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood","volume":"100","author":"Abbott","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0575","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpag.2010.06.003","article-title":"Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought","volume":"24","author":"Bronstein","year":"2011","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.lfs.2024.123221_bb0580","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0585","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123221_bb0590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123221_bb0595","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s12905-023-02732-2","article-title":"Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care","volume":"23","author":"Sydora","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.lfs.2024.123221_bb0605","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humupd\/dmad027","article-title":"Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis","volume":"30","author":"Pea","year":"2024","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.lfs.2024.123221_bb0610","series-title":"Gynaecology E-Book: Expert Consult: Online and Print","first-page":"128","article-title":"Hormones: their action and measurement in gynaecological practice","author":"Nelson","year":"2010"},{"key":"10.1016\/j.lfs.2024.123221_bb0615","series-title":"27 Biochemical Endocrinology, Medical Biochemistry: Medical Biochemistry E-Book","first-page":"368","author":"Church","year":"2018"},{"key":"10.1016\/j.lfs.2024.123221_bb0620","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14740\/jem716","article-title":"Luteinizing hormone to follicle-stimulating hormone ratio significantly correlates with androgen level and manifestations are more frequent with hyperandrogenemia in women with polycystic ovary syndrome","volume":"11","author":"Morshed","year":"2021","journal-title":"J. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2024.123221_bb0625","doi-asserted-by":"crossref","first-page":"259","DOI":"10.46542\/pe.2023.234.259263","article-title":"An observational analysis of blood and urine testosterone in diagnosis of polycystic ovarian syndrome","volume":"23","author":"Fernanda","year":"2023","journal-title":"Pharm. Educ."},{"key":"10.1016\/j.lfs.2024.123221_bb0630","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cca.2015.08.019","article-title":"Testosterone, free testosterone, and free androgen index in women: reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome","volume":"450","author":"Bui","year":"2015","journal-title":"ClinicaChimica Acta"},{"key":"10.1016\/j.lfs.2024.123221_bb0635","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.rbmo.2020.07.013","article-title":"The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome","volume":"41","author":"Yang","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.lfs.2024.123221_bb0640","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/diagnostics13050907","article-title":"The role of serum anti-mullerian hormone measurement in the diagnosis of polycystic ovary syndrome","volume":"13","author":"Sivanandy","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.lfs.2024.123221_bb0645","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12291-022-01058-4","article-title":"Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters","volume":"38","author":"Sumji","year":"2023","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.lfs.2024.123221_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03007995.2023.2204768","article-title":"Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome","volume":"39","author":"Timur","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.lfs.2024.123221_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0660","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/2141-9248.113660","article-title":"Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone","volume":"3","author":"Chakrabarti","year":"2013","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0665","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/rg.326125503","article-title":"Polycystic ovarian syndrome: role of imaging in diagnosis","volume":"32","author":"Lee","year":"2012","journal-title":"Radiographics"},{"key":"10.1016\/j.lfs.2024.123221_bb0670","series-title":"ECR Congress","article-title":"Ultrasound in polycystic ovarian syndrome: What? when? how? why? who?","volume":"44","author":"Amreen","year":"2022"},{"key":"10.1016\/j.lfs.2024.123221_bb0675","series-title":"Transvaginal Ultrasound Diagnosis of Polycystic Ovarian Syndrome and its Correlation with Biochemical Parameters","author":"Arpitha","year":"2020"},{"key":"10.1016\/j.lfs.2024.123221_bb0680","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/bmjqs-2021-013311","article-title":"Patient-centred outcomes of imaging tests: recommendations for patients, clinicians and researchers","volume":"32","author":"Thompson","year":"2023","journal-title":"BMJ Qual. Saf."},{"key":"10.1016\/j.lfs.2024.123221_bb0685","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0690","doi-asserted-by":"crossref","DOI":"10.21608\/bmfj.2023.176005.1715","article-title":"Evaluation of the cardiovascular risk in women with PCOS","author":"Al-Kassas","year":"2023","journal-title":"Benha Med. J."},{"key":"10.1016\/j.lfs.2024.123221_bb0695","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ogrm.2022.06.001","article-title":"Polycystic ovarian syndrome: diagnosis and management of related infertility","volume":"32","author":"Yadav","year":"2022","journal-title":"Obstet. Gynaecol. Reprod. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0705","first-page":"1304","article-title":"3 CpG methylation biomarkers for the diagnosis of polycystic ovary syndrome (PCOS) in blood samples","volume":"25","author":"Xie","year":"2023","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.lfs.2024.123221_bb0710","doi-asserted-by":"crossref","first-page":"ii69","DOI":"10.1093\/humrep\/dead191","article-title":"Deciphering the DNA methylome in women with PCOS diagnosed using the new international evidence-based guidelines","volume":"38","author":"Wang","year":"2023","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2024.123221_bb0715","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/biom13071101","article-title":"Circular RNA as a novel regulator and promising biomarker in polycystic ovary syndrome","volume":"13","author":"Jing","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.123221_bb0720","first-page":"27","article-title":"Galectin-1 as a potential diagnostic biomarker in polycystic ovary syndrome","author":"Aladag","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0725","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","article-title":"Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS","volume":"448","author":"Wang","year":"2015","journal-title":"ClinicaChimica Acta."},{"key":"10.1016\/j.lfs.2024.123221_bb0730","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12958-021-00762-9","article-title":"Urinary vitamin D-binding protein as a marker of ovarian reserve","volume":"19","author":"Li","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.123221_bb0740","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.lfs.2024.123221_bb0745","first-page":"106","article-title":"Diagnosis and treatment of polycystic ovary syndrome","volume":"94","author":"Williams","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.lfs.2024.123221_bb0750","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ijerph18010233","article-title":"Development and effects of college-based lifestyle modification program for menstrual health of young adult women with irregular menses: a randomized controlled trial","volume":"18","author":"Park","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.lfs.2024.123221_bb0755","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1515\/openhe-2022-0008","article-title":"Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review","volume":"3","author":"Zehravi","year":"2022","journal-title":"Open Health."},{"issue":"1","key":"10.1016\/j.lfs.2024.123221_bb0760","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome\u2013beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.lfs.2024.123221_bb0765","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/nu11102278","article-title":"Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS)","volume":"11","author":"Barrea","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2024.123221_bb0770","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/s41467-020-19003-5","article-title":"Defining the impact of dietary macronutrient balance on PCOS traits","volume":"11","author":"Rodriguez Paris","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123221_bb0775","series-title":"The Effects of Physical and Sedentary Activity on Metabolic Syndrome as Risk Factors for Polycystic Ovary Syndrome, University of Louisiana at Lafayette","author":"Humphrey","year":"2020"},{"key":"10.1016\/j.lfs.2024.123221_bb0780","first-page":"18","article-title":"All women with PCOS should be treated for insulin resistance","volume":"97","author":"Dunaif","year":"2013","journal-title":"Natl. Inst. Heal. [Internet]."},{"key":"10.1016\/j.lfs.2024.123221_bb0785","article-title":"Rhamnocitrin attenuates ovarian fibrosis in rats with letrozole-induced experimental polycystic ovary syndrome","author":"Zhou","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2024.123221_bb0790","first-page":"95","article-title":"A review of first line infertility treatments and supporting evidence in women with polycystic ovary ACCEPTED MANUSCRIPT information classification: general syndrome","volume":"7","author":"Costello","year":"2019","journal-title":"Med. Sci. (Basel)."},{"key":"10.1016\/j.lfs.2024.123221_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.lfs.2024.123221_bb0800","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09513590.2016.1188280","article-title":"Serum antiMullerian hormone levels after ovarian drilling for the second-line treatment of polycystic ovary syndrome: a pilot-randomized study comparing laparoscopy and transvaginal hydrolaparoscopy","volume":"33","author":"Giampaolino","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0805","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/13543784.2020.1781815","article-title":"Current and experimental drug therapy for the treatment of polycystic ovarian syndrome","volume":"29","author":"Della Corte","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2024.123221_bb0810","first-page":"5","article-title":"The role of alpha-Lactalbumin with Myoinositol in the treatment of PCOS: a review","volume":"8","author":"Pandya","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.lfs.2024.123221_bb0815","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1479-828X.2012.01448.x","article-title":"The treatment of infertility in polycystic ovary syndrome: a brief update","volume":"52","author":"Costello","year":"2012","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.lfs.2024.123221_bb0825","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1210\/en.2019-00428","article-title":"Neuroendocrine impairments of polycystic ovary syndrome","volume":"160","author":"Ruddenklau","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2024.123221_bb0830","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/ijerph19053089","article-title":"Neuroendocrine determinants of polycystic ovary syndrome","volume":"19","author":"Szeliga","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.lfs.2024.123221_bb0835","first-page":"12","article-title":"Risk factors for ovarian Cancer: a literature review","author":"Almisawi","year":"2022","journal-title":"Indian J. Public Health Res. Dev."},{"key":"10.1016\/j.lfs.2024.123221_bb0840","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-16-1063","article-title":"Management of endocrine disease: polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0845","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","article-title":"The role of MiRNA in polycystic ovary syndrome (PCOS)","volume":"706","author":"Chen","year":"2019","journal-title":"Gene"},{"issue":"14","key":"10.1016\/j.lfs.2024.123221_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411489","article-title":"The role of miRNAs in the development, proliferation, and progression of endometrial cancer","volume":"24","author":"Bogaczyk","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0855","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1269266","article-title":"Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS)","volume":"14","author":"Hadidi","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"9","key":"10.1016\/j.lfs.2024.123221_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163756","article-title":"The role of serum microRNA-6767-5p as a biomarker for the diagnosis of polycystic ovary syndrome","volume":"11","author":"Song","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.lfs.2024.123221_bb0865","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/ijms25020903","article-title":"The role of MicroRNA, long non-coding RNA and circular RNA in the pathogenesis of polycystic ovary syndrome: a literature review","volume":"25","author":"Nasser","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2024.123221_bb0870","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2176\/nmc.ra.2020-0049","article-title":"Historic overview of genetic engineering technologies for human gene therapy","volume":"60","author":"Tamura","year":"2020","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.lfs.2024.123221_bb0875","first-page":"002","article-title":"Genetic and epigenetic landscape for drug development in polycystic ovary syndrome","author":"Chen","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2024.123221_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314663","article-title":"Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)\u2014searching for epigenetic factors","volume":"23","author":"Szukiewicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0885","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","article-title":"Epigenetic inheritance of polycystic ovary syndrome\u2014challenges and opportunities for treatment","volume":"17","author":"Stener-Victorin","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123221_bb0890","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12015-023-10627-w","article-title":"Induced pluripotent stem cells as a possible approach for exploring the pathophysiology of polycystic ovary syndrome (PCOS)","volume":"20","author":"Khatun","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.lfs.2024.123221_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02472-w","article-title":"Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10","volume":"12","author":"Chugh","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2024.123221_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.659268","article-title":"How to screen and prevent metabolic syndrome in patients of PCOS early: implications from metabolomics","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0905","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.3390\/ijms21144853","article-title":"Metabolomic insight into polycystic ovary syndrome\u2014an overview","volume":"21","author":"Rajska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-4060-6","article-title":"Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: study protocol for a randomized controlled trial","volume":"21","author":"Ni","year":"2020","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.lfs.2024.123221_bb0915","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1210\/jc.2015-2807","article-title":"Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome","volume":"101","author":"Tosi","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.lfs.2024.123221_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112031","article-title":"Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics","volume":"142","author":"Pei","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"06","key":"10.1016\/j.lfs.2024.123221_bb0925","article-title":"Metabolomics approach for the etiopathogenesis of polycystic ovarian syndrome","volume":"14","author":"Bhattacharyya","year":"2024","journal-title":"Natl. J. Physiol. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123221_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110958","article-title":"Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.lfs.2024.123221_bb0935","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/ijms22042048","article-title":"Microbiome and PCOS: state-of-art and future aspects","volume":"22","author":"Giampaolino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123221_bb0940","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and vaginal microbiomes in PCOS: implications for women\u2019s health","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.lfs.2024.123221_bb0945","series-title":"Contemporary Issues in Communication, Cloud and Big Data Analytics: Proceedings of CCB, Springer Singapore. 2020","first-page":"453","article-title":"Artificial intelligence in diagnosis of polycystic ovarian syndrome","author":"Roy","year":"2022"},{"key":"10.1016\/j.lfs.2024.123221_bb0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-015-0115-z","article-title":"Identification of subjects with polycystic ovary syndrome using electronic health records","volume":"13","author":"Castro","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123221_bb0955","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41746-024-01006-x","article-title":"The prospect of artificial intelligence to personalize assisted reproductive technology","volume":"7","author":"Hanassab","year":"2024","journal-title":"npj Digit. Med."},{"key":"10.1016\/j.lfs.2024.123221_bb0960","first-page":"1","article-title":"Polycystic Ovary Syndrome (PCOS) diagnostic methods in machine learning: a systematic literature review","author":"Arora","year":"2024","journal-title":"Multimed. Tools Appl."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524008117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T07:05:50Z","timestamp":1738134350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524008117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":173,"alternative-id":["S0024320524008117"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123221","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome: Recent research and therapeutic advancements","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123221"}}